Risankizumab Archive - medupdate

Livestream
On-Demand
Industrie

Livestream
On-Demand
Industrie

Login my med-update

logout my med-update

Schlagwort

Risankizumab

CED I

ADDapt-Studie / C. ulcerosa / CED / Darmmikrobiom / Infliximab / Intestinaler Ultraschall / Lebensmittel-Emulgatoren / Morbus Crohn / PROFILE-Studie / Risankizumab / Thiopurinen / Upadacitinib

CED I

Biologikatherapie / Darmerkrankungen / EVOLVE-Studie / IFX-Therapie / Ileozökalresektion / Kono-S-Anastomose / Mikrobiom-Analysen / Morbus Crohn / REACT-2-Studie / Risankizumab / RUN-CD-Studie / SEAVUE-Studie / STARDUST-Studie / Ustekinumab / Vedolizumab

CED I

Biologikatherapie / Darmerkrankungen / EVOLVE-Studie / IFX-Therapie / Ileozökalresektion / Kono-S-Anastomose / Mikrobiom-Analysen / Morbus Crohn / REACT-2-Studie / Risankizumab / RUN-CD-Studie / SEAVUE-Studie / STARDUST-Studie / Ustekinumab / Vedolizumab

Spondyloarthritiden II

Spondyloarthritiden II

Adalimumab / Bimekizumab / Bisphosphonat / Guselkumab / Ixekizumab / Izokibep / Komorbiditäten / Leberzhirrose / Psoriasis / Remtolumab / Risankizumab / SAPHO / Secukinumab / TNFi / Tofacitinib

med update GmbH
Hagenauer Straße 53
65203 Wiesbaden

AGB Impressum Datenschutz Cookie Einstellungen